Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry

INTRODUCTION: Patients with active rheumatoid arthritis (RA) despite anti–tumor necrosis factor(anti-TNF)agent treatment can switch to either a subsequent anti-TNF agent or a biologic with an alternative mechanism of action, such as rituximab; however, there are limited data available to help physic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Main Authors: Harrold, Leslie R., Reed, George W., Magner, Robert, Shewade, Ashwini, John, Ani, Greenberg, Jeffrey D., Kremer, Joel M.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574482/
https://ncbi.nlm.nih.gov/pubmed/26382589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0776-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares